These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2899647)

  • 1. Dopamine autoreceptor agonists as potential antipsychotics. 1. (Aminoalkoxy)anilines.
    Jaen JC; Wise LD; Heffner TG; Pugsley TA; Meltzer LT
    J Med Chem; 1988 Aug; 31(8):1621-5. PubMed ID: 2899647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine autoreceptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-ones.
    Jaen JC; Wise LD; Heffner TG; Pugsley TA; Meltzer LT
    J Med Chem; 1991 Jan; 34(1):248-56. PubMed ID: 1671416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist.
    Pugsley TA; Christofferson CL; Corbin A; DeWald HA; Demattos S; Meltzer LT; Myers SL; Shih YH; Whetzel SZ; Wiley JN
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1147-58. PubMed ID: 1361570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agent.
    Wright JL; Downing DM; Feng MR; Hayes RN; Heffner TG; MacKenzie RG; Meltzer LT; Pugsley TA; Wise LD
    J Med Chem; 1995 Dec; 38(26):5007-14. PubMed ID: 8544176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomers.
    Meltzer LT; Caprathe BW; Christoffersen CL; Corbin AE; Jaen JC; Ninteman FW; Pugsley TA; Serpa KA; Shih YH; Whetzel SZ
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1177-89. PubMed ID: 8103791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine autoreceptor agonists as potential antipsychotics. 3.6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine.
    Caprathe BW; Jaen JC; Wise LD; Heffner TG; Pugsley TA; Meltzer LT; Parvez M
    J Med Chem; 1991 Sep; 34(9):2736-46. PubMed ID: 1680195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist properties.
    Jaen JC; Wise LD; Caprathe BW; Tecle H; Bergmeier S; Humblet CC; Heffner TG; Meltzer LT; Pugsley TA
    J Med Chem; 1990 Jan; 33(1):311-7. PubMed ID: 1967314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects.
    Meltzer LT; Christoffersen CL; Corbin AE; Ninteman FW; Serpa KA; Wiley JN; Wise LD; Heffner TG
    J Pharmacol Exp Ther; 1995 Aug; 274(2):912-20. PubMed ID: 7636754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of a series of 8-[3-[bis(4-fluorophenyl)amino]propyl]-1-aryl-1,3,8- triazaspiro[4.5]decan-4-ones as potential antipsychotic agents.
    Wise LD; Pattison IC; Butler DE; DeWald HA; Lewis EP; Lobbestael SJ; Tecle H; Coughenour LL; Downs DA; Poschel BP
    J Med Chem; 1985 Dec; 28(12):1811-7. PubMed ID: 2866248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (5-Amino-1,3-dimethyl-1H-pyrazol-4-yl)(2-fluorophenyl)methanones . A series of novel potential antipsychotic agents.
    Wise LD; Butler DE; DeWald HA; Lustgarten D; Coughenour LL; Downs DA; Heffner TG; Pugsley TA
    J Med Chem; 1986 Sep; 29(9):1628-37. PubMed ID: 2875184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationships.
    Glase SA; Akunne HC; Heffner TG; Jaen JC; MacKenzie RG; Meltzer LT; Pugsley TA; Smith SJ; Wise LD
    J Med Chem; 1996 Aug; 39(16):3179-87. PubMed ID: 8759640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agents.
    Wright JL; Caprathe BW; Downing DM; Glase SA; Heffner TG; Jaen JC; Johnson SJ; Kesten SR; MacKenzie RG; Meltzer LT
    J Med Chem; 1994 Oct; 37(21):3523-33. PubMed ID: 7932581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1H-indoles as dopamine D2 partial agonists and autoreceptor agonists.
    Wustrow DJ; Smith WJ; Corbin AE; Davis MD; Georgic LM; Pugsley TA; Whetzel SZ; Heffner TG; Wise LD
    J Med Chem; 1997 Jan; 40(2):250-9. PubMed ID: 9003524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,3-Dialkyl-4-(iminoarylmethyl)-1H-pyrazol-5-ols. A series of novel potential antipsychotic agents.
    Wise LD; Butler DE; DeWald HA; Lustgarten DM; Pattison IC; Schweiss DN; Coughenour LL; Downs DA; Heffner TG; Pugsley TA
    J Med Chem; 1987 Oct; 30(10):1807-12. PubMed ID: 2888897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activities.
    Florvall L; Ogren SO
    J Med Chem; 1982 Nov; 25(11):1280-6. PubMed ID: 6128419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
    Heffner TG; Downs DA; Meltzer LT; Wiley JN; Williams AE
    J Pharmacol Exp Ther; 1989 Oct; 251(1):105-12. PubMed ID: 2571712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic SCH 23390 treatment on dopamine autoreceptor function in rat brain.
    Lappalainen J; Hietala J; Sjöholm B; Syvälahti E
    Eur J Pharmacol; 1990 Apr; 179(3):315-21. PubMed ID: 1973105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
    Martin GE; Haubrich DR; Williams M
    Eur J Pharmacol; 1981 Nov; 76(1):15-23. PubMed ID: 7318920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives.
    Oshiro Y; Sato S; Kurahashi N; Tanaka T; Kikuchi T; Tottori K; Uwahodo Y; Nishi T
    J Med Chem; 1998 Feb; 41(5):658-67. PubMed ID: 9513593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.